Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zigg Capital is a New York-based venture capital firm focused primarily on real estate technology, construction technology, retail technology, and adjacent software-enabled businesses. The firm describes its mission as accelerating the combination of real property and technology to improve quality of life, work, and communities. It is not a biotech, pharma, life sciences, or healthcare operating company, though it may have made occasional investments in companies that touch healthcare or enterprise healthcare software. Zigg Capital appears to be an active private investment firm rather than a drug developer, medical device company, CRO, or CDMO. For biotech analyst purposes, the key takeaway is that this is an investor/fund manager, not a therapeutics pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zigg Capital.